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Breast MRI for Evaluating Patients with
Metastatic Axillary Lymph Node and
Initially Negative Mammography and
Sonography
Objective: We wanted to investigate the ability of breast MR imaging to identify
the primary malignancy in patients with axillary lymph node metastases and ini-
tially negative mammography and sonography, and we correlated those results
with the conventional imaging.
Materials and Methods: From September 2001 to April 2006, 12 patients with
axillary lymph node metastases and initially negative mammography and sonog-
raphy underwent breast MR imaging to identify occult breast carcinoma. We ana-
lyzed the findings of the MR imaging, the MR-correlated mammography and the
second-look sonography. We followed up both the MR-positive and MR-negative
patients. 
Results: MR imaging detected occult breast carcinoma in 10 of 12 (83%)
patients. Two MR-negative patients were free of carcinoma in the ipsilateral
breast during their follow-up period (39 and 44 months, respectively). In nine out
of 10 patients, the MR-correlated mammography and second-look sonography
localized lesions that were not detected on the initial exam. All the non-MR-corre-
lated sonographic abnormalities were benign.
Conclusion: Breast MR imaging can identify otherwise occult breast cancer in
patients with metastatic axillary lymph nodes. Localization of the lesions through
MR-correlated mammography and second-look sonography is practically feasible
in most cases.
he manifestation of an isolated metastatic axillary lymph node without
any clinical and radiologic evidence of primary breast cancer is
uncommon, but this disease most commonly originates from breast
cancer in women (1). For these cases, the traditional therapy has been upper outer
quadrantectomy or blind mastectomy with axillary lymph node dissection, with or
without radiation (2). However, 30 40% of the upper outer quadrantectomy or blind
mastectomy specimens show no histologic evidence of carcinoma, and the survival
rate of patients who undergo blind mastectomy with axillary dissection is similar to
those who undergo axillary dissection only (3, 4). Breast MRI techniques have
improved significantly in recent years, and MRI with dynamic enhancement has been
established as an important imaging modality for evaluating breast cancer with the
highest sensitivity (5). Therefore, the goal of this study was to investigate the ability of
breast MR imaging to identify the primary malignant focus in patients with metastatic
axillary lymph nodes and initially negative mammography and sonography, and to
correlate the results with the conventional imaging. 
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TMATERIALS AND METHODS
Patients 
From September 2001 to April 2006, 26 patients
presenting with metastatic axillary lymph nodes and
without any clinical evidence of breast cancer visited our
hospital. In 11 cases, primary breast cancers were detected
in the ipsilateral breasts by mammography (n = 3) or US (n
= 7) or both (n = 1). Two cases had a history of contralat-
eral breast cancer and they had received modified radial
mastectomy and chemotherapy three and four years ago,
respectively. In one case, the diagnosis of the core needle
biopsy of the axillary lymph node was metastatic poorly
differentiated carcinoma or medullary carcinoma, but the
final diagnosis after axillary lymph node dissection was
anaplastic large cell lymphoma. The remaining 12 patients,
who showed no evidence of primary breast cancer upon
clinical examination or on the initial mammography and
sonography, underwent breast MR imaging to evaluate the
presence of occult breast carcinoma; it was these 12
patients who made up the study population. All 12 patients
had malignant axillary lymph nodes that were pathologi-
cally shown to be metastatic adenocarcinomas by
ultrasound (US)-guided core needle biopsy (n = 11) and
excision biopsy (n = 1). All these patients were female and
they ranged in age from 42 to 78 years (mean age: 55
years).
All the available images of the patients from the
referring hospital, including 10 mammograms, nine US and
one PET, were negative. Ten patients had both negative
mammograms and US; two patients had negative
mammograms and US with probable benign nodules.
Breast MR Imaging 
All the patients were imaged in the prone position using
a dedicated surface breast coil. Breast MR imaging was
performed on a 1.5-T system (Signa CV/I; General Electric
Medical System, Milwaukee, WI) for eight cases and on a
3.0-T system (Interna; Philips Medical Systems, Best, the
Netherlands) for three cases, and on both systems for one
case. MR imaging consisted of a fat-suppressed, sagittal, 3-
dimensional, gradient echo sequence and the dynamic
enhanced images. Imaging on the 1.5-T scanner covered a
single breast with a minimum repetition time and echo
time (17.3/1.3 ms), a 60 flip angle, a 24-cm field of view,
1-mm to 2-mm sections with no gap, a 256 192 matrix,
one excitation and a scan time of 3-4 minutes. Imaging on
the 3.0-T scanner covered both breasts with a minimum
repetition time and echo time (8.7/4.3 ms for the axial
dynamic images; 16/4.1 ms for the sagittal dynamic
images), a 20 flip angle, a 27-cm field of view, 1.5-mm
sections with no gap, a 512 512 matrix and a scan time of
2 3 minutes.
For the dynamic contrast enhancement, a 0.1 mmol/kg
bolus of gadopentetate dimeglumine (Magnevist; Berlex
Laboratories, Wayne, NJ) was injected; this was followed
by a 10-mL saline flush. Two and three sequential postcon-
trast images were obtained with no delay on the 1.5-T and
3.0-T scanners, respectively, and these began immediately
after the saline flush at the same slice position and location.
After examination, two subtraction images were made
automatically on a pixel-by-pixel basis: the un-enhanced
images were subtracted from the early postcontrast images
(standard subtraction), and the last postcontrast images
were subtracted from the early postcontrast images
(reverse subtraction). The reformatted images with a
maximum intensity projection were then created from the
standard and reverse subtraction images. 
Interpretation of the Breast MR Images
The MR images were interpreted prospectively on soft
copy with using PACS (picture archiving and communica-
tion system, General Electric Medical System) that allowed
manual window settings and optimization of the parame-
ters. A radiologist, who was aware of the patient’s clinical
history and who had seen all available imaging informa-
tion, including the mammograms and sonograms,
interpreted all the images. The breast lesions were
described using the Breast Imaging Reporting and Data
System (BI-RADS) MR lexicon (6).
A lesion was considered suspicious if it was visualized as
(a) a mass with irregular shape, a mass with irregular or
spiculated margin, or a mass with rim enhancement, (b)
non-mass-like enhancement that showed a clumped linear-
ductal enhancement, clumped segmental enhancement and
regional enhancement with ill-defined or irregular borders
or with architectural distortion, or (c) a mass or non-mass-
like enhancement with early washout. 
Management of Lesions after MRI
The previous mammography and US images were
retrospectively reviewed along with any information
gleaned from the MR images; any positive findings, includ-
ing benign or probable benign lesions in the areas
corresponding to suspicious enhancements on the MRI,
were confirmed by US-guided or mammography-guided
biopsy. If retrospective review of the previous mammogra-
phy or US images was not available or if this was negative,
then MR-correlated mammography or a second-look US
examination that specifically targeted the area of
suspicious MR enhancement was performed. The benign
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biopsy in the area of suspicious MR enhancement were
followed by localization with excision biopsy.
Since MR-guided localization and biopsy were not
available at our institution, those lesions with suspicious
enhancement on MRI, but with no abnormality on
mammography or the US images, underwent mastectomy. 
RESULTS
Suspicious lesions were detected on breast MRI in 10
(83%) of the 12 patients. The pathology of all the lesions
was proven to be primary breast carcinoma. 
A complete summary of the 12 patients presenting with
axillary lymph node metastases is given in Table 1. All the
patients had mammography and US examinations
conducted before undergoing breast MRI. All 12 patients
were transferred from other hospitals with negative
mammography and US images or they were transferred
without these images. Seven of them again received
mammography and US examinations at our hospital, and
the other five of them were diagnosed by the images that
were obtained from other hospitals. 
Before MR imaging, 10 out of the 12 patients had no
abnormal findings based on the conventional images, while
two patients had category 3 nodules observed on US.
These two category 3 nodules did not correlate with the
MR findings and they were diagnosed as a foreign body
reaction and stromal fibroses by US-guided core needle
biopsy.
MRI of the breast showed suspicious lesions in 10
patients, and these lesions had been negative on the prior
conventional images. MR-guided second-look US examina-
tions were performed in each of those 10 patients, as well
as performing mammography in four patients. Subsequent
localization of the lesions detected on MRI was possible on
mammography (n = 1), US (n = 4) or on both examinations
(n = 4) in nine out of 10 patients. In three patients, the
lesions localized on MR-guided second-look examinations
were category 4 there were two cases of suspicious nodules
less than 1 cm in size on US (Fig. 1) and one case of faint
pleomorphic calcifications with a segmental distribution on
the mammogram (Fig. 2). Category 3 lesions were found in
five patients with 3-mm to 8-mm sized benign-looking
nodules being seen on US (Fig. 3). A category 2 lesion was
found in one patient who had a few benign cysts (Fig. 4).
All the lesions localized on the MR-correlated mammogra-
phy or the MR-guided second-look US images were found
to be malignant after US-guided core needle biopsy (n =
5), US-guided fine needle aspiration (n = 1), surgical
excision after US-guided localization (n = 2) or after
mammography-guided localization (n = 1). The MR-guided
second-look examination failed to localize the lesion in one
patient who had a 1.8-cm linear non-mass-like enhance-
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Table 1. Summary of the 12 Patients with Metastatic Axillary Lymph Node(s) and Initially Negative Mammography and
Sonography
MG / US   Localization on MR-correlated MG /  Size
prior to MR
MR
second look US
Dx
(mm)
Location Treatment
1( ) / ( ) (+) (+) / (+) IDC 4 UIQ Lumpectomy + AC
2( ) / ( ) (+) / (+) IDC
/ (+) ( ) FB reaction 5 LOQ Lumpectomy + AC
3( ) / ( ) (+) / (+) IDC 7 LIQ BCS
/ (+) ( )S F
4( ) / ( ) (+) (+) / (+) Tubular ca.  
ADHs 3 LOQ BCS
5( ) / ( ) (+) ( ) / (+) IDC 7 UOQ BCS
6( ) / ( ) (+) (+) / ( ) Multifocal IDCs 3 Lower center BCS
7( ) / ( ) (+) (+) / (+) Multifocal IDCs 7 LIQ MRM
8( ) / ( ) (+) ( )/  ( ) DCIS Mid outer MRM
9( ) / ( ) (+) (+) / (+) IDC X 2  LOQ  CTx, RTx
10 ( ) / ( ) (+) / (+) IDC X 2 LIQ CTx, RTx
11 ( ) / ( )( ) CTx, RTx + AC
12 ( ) / ( )( )( )* / ( )* CTx, RTx + AC
Note. MG = mammography, US = ultrasound, Dx = diagnosis, IDC = invasive ductal carcinoma, DCIS = ductal carcinoma in situ, FB = foreign body, 
ADH = atypical ductal hyperplasia, SF = stromal fibrosis, AC = axillary clearance, BCS = breast conserving surgery, MRM = modified radical mastectomy,
CTx = chemotherapy, RTx = radiation therapy, Ca. = carcinoma, UIQ = upper inner quadrant, UOQ = upper outer quadrant, LIQ = lower inner quadrant,
LOQ = lower outer quadrant
Category 3 nodules detected on prior US and that were not correlated with the MR findings
* Follow up study after 9 months.  Case with Distant metastasisment with focal wash out on MRI. This lesion was found to
be ductal carcinoma in situ (DCIS) after performing
modified radical mastectomy (Fig. 5). 
After histologic confirmation of the primary breast
malignancies for 10 MR-detected lesions, two patients
underwent lumpectomy following the US-guided localiza-
tion, four patients were treated with breast conserving
surgery (BCS) after US or mammography-guided localiza-
tion, and one patient underwent modified radical mastec-
tomy (MRM) for multifocal lesions. As noted above, the
patient who had a suspicious lesion observed on MRI that
was not otherwise localized, this patient received MRM as
well. Two patients were treated with chemotherapy and
radiation therapy without surgical intervention due to their
Breast MRI in Patients with Axillary Nodal Metastasis Alone on Other Imaging Studies
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ABC
Fig. 1. A 78-year-old woman with
palpable left axillary lymph node
metastasis. The initial mammogram (A)
and US showed negative findings in the
breast. Two small enhancing nodules
(arrows) with a washout pattern were
visible in the left lower breast on the
contrast enhanced-MR images (B, C).
Subsequent MR-guided second-look US
examinations revealed two small low
echoic nodules (3 4 mm) with indistinct
margins (arrows) that were not seen on
the prior US study (D, E). US-guided
core needle biopsy revealed invasive
ductal carcinomas.
DE
Fig. 2. A 43-year-old woman with
palpable left axillary lymph node
metastasis. The mammogram and US
images from another hospital showed
negative findings. On the maximun
intensity projection image of the contrast
enhanced-MRI (A), segmental clumped
or stippled enhancements (box) were
noted in the left lower breast. MR-
correlated mammography (B) showed
the segmental distribution of faint
amorphous microcalcifications in that
area (box). Breast conserving surgery
after mammography-guided wire
localization revealed multifocal invasive
ductal carcinomas up to 3 mm in size. ABmultifocal breast cancers with distant metastases. 
Of the 10 cases that underwent surgical treatment or
biopsy, five cases were invasive ductal carcinomas, one
was tubular carcinoma and one was ductal carcinoma in
situ. Four of the patients with invasive ductal carcinoma
had multiple lesions, and the patient with tubular
carcinoma had multiple areas of atypical ductal hyperplasia
around the carcinoma. The mean size of the surgically
removed invasive carcinomas was 4.8 mm (range: 3 7
mm). 
In two patients with negative findings on both MRI and
the conventional images, there was still no evidence of the
primary malignancy in the ipsilateral breast on the conven-
tional images or on the follow-up MRI during the follow-up
periods of 39 and 44 months, respectively. 
DISCUSSION
With its recent technical advances, contrast-enhanced
MRI plays an important role in identifying primary breast
cancer, for defining the extent of tumor and for helping
decide the therapeutic plans (1). While mammography is
Ko et al.
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Fig. 3. A 53-year-old woman with palpable left axillary lymph node metastasis. The mammogram (A) and US showed no abnormal
findings in the breast. The contrast-enhanced MR image (B) showed 5 mm nodular enhancement without a washout pattern (arrow) in
the left lower outer breast. On the MR-guided second-look US examination (C), a well-defined flat nodular lesion (arrow) was identified,
and invasive ductal carcinoma was diagnosed by US-guided localization and excision.
AB C
Fig. 4. A 42-year-old woman with palpable left axillary lymph node metastasis. The mammogram (A) showed extremely dense breast
parenchyma without abnormal findings in the breast. The initial screening US was normal. The standard subtraction image (B) of the
contrast-enhanced breast MRI showed an enhancing nodule, about 7 mm in size, in the left lower breast (arrow) with a washout pattern.
The MR-guided second look US examination localized a few benign cysts in that area (arrows) (C). US-guided fine needle aspiration
revealed malignant cells.
AB Cthe primary imaging modality used to evaluate breast
lesions, the false negative rate for mammography has been
reported to be about 30% (7, 8). The sensitivity of
mammography is especially limited when the lesion is
within dense breast parenchyma, and it is often as low as
45% (9). Among mammography, US and MRI, MRI is the
most sensitive method for evaluating breast cancer and it is
well recognized that MRI can detect otherwise occult
breast cancer (5, 9, 10).
A few previous reports that detailed the MR images of
patients with axillary lymph node metastases, and the
patients had prior negative clinical and mammography
findings, demonstrated 36%, 75% and 86% rates of
detecting cancer by breast MRI, respectively (1, 11, 12). In
another previous study on patients with axillary lymph
node metastasis and negative clinical, mammographic and
US findings, the investigators showed a lesion detection
rate of 64% with breast MRI, and 67% of the detected
lesions were found to be primary breast cancer (13). The
reported mean size of the lesions visible by breast MRI
alone was 14.6 mm (14), while the mean lesion size
detected by MRI in our study was 4.8 mm. 
The results of mammography and US depend on the
quality of the mammogram and the persons who interpret
the mammogram and perform the US examination. In our
study, when the quality of the initial mammogram from
other hospital was not satisfactory, we then performed
mammography of the ipsilateral breast again for the same
patient. Two radiologists interpreted all the mammograms
and one of them was a board-certified experienced radiolo-
gist who had worked in the field of breast imaging for
more than 10 years. More than six persons performed this
study’s US examinations, from a resident with two years
experience in US examination to a board certified experi-
enced radiologist with more than 10 years experience in
breast US. This can be the limitation of our study, but the
lesions detected by MRI alone were smaller than those
detected by MRI in the reported cases (14). 
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Fig. 5. A 57-year-old woman with
palpable right axillary lymph node
metastasis. The mammogram (A) and
US showed negative findings in the
breast. The standard subtraction image
of the contrast enhanced-MRI (B)
showed a 1.8-cm sized area of linear
enhancement with an early washout
pattern, suggesting malignancy in the
outer portion of the right breast. MR-
guided second-look US (C) and spot-
compression with magnification
mammography (D), which targeted the
areas of MR-detected lesion through the
use of a vitamin E capsule attached to
the surface of the right breast overlying
the MR-detected lesion, could not find
the corresponding lesion. After modified
radical mastectomy, ductal carcinoma in
situ (0.9 cm in extent) was found in the
right outer breast.In our study, breast MRI showed suspicious lesions in
83% (10/12) of the patients who had prior negative
clinical, mammography and US findings. Instead of
performing the traditional blind mastectomy or upper
outer quadrantectomy, eight patients received surgery: two
lumpectomies, four BCSs and two MRMs. In addition, two
patients were treated with chemotherapy and radiation
therapy based on the information regarding the site and
extent of their primary malignancy. As a result of the
confirmed information about the lesions, all the patients
were treated appropriately and conservatively, with the
exception of one patient who received MRM for a
suspicious lesion on MRI that was not otherwise localized.
It is worthwhile to note that six patients were able to avoid
unnecessary mastectomy or upper outer quadrantectomy,
as the primary breast carcinoma was located in the upper
outer quadrant in only one patient. 
The one case that was localized only on MRI and the
patient underwent MRM was pure DCIS. Historically, the
reported incidence of axillary metastasis in patients with
DCIS is 1-2%, but the prevalence of positive lymph nodes
in patients with pure DCIS is approximately 2 13% with
performing immunohistochemical staining (15, 16). Node
metastasis is usually observed in the sentinel lymph node
only in patients with DCIS (17), but in our case, four
lymph nodes were revealed to have malignant cells after
MRM.
Since MRI has a very low false-negative rate (9, 15), we
did not perform blind mastectomy or quadrantectomy in
the two patients who had negative findings on MRI. They
have shown no evidence of malignancy in their breasts
during the follow-up period (39 and 44 months, respec-
tively) to date.
Therefore, we suggest that before developing a therapeu-
tic plan, breast MRI must be performed for those patients
with axillary lymph node metastasis and who are without
evidence of primary breast cancer.
Although contrast-enhanced MRI has the highest
sensitivity among the many imaging modalities for the
breast, the specificity of breast MRI is low (9, 10, 16).
Therefore, preoperative biopsy or localization of the MR-
detected lesion is necessary (17). Yet MR imaging-guided
biopsy or localization requires commercially available MRI
guiding equipment. Also, the cost-effectiveness of MRI-
guided biopsy or localization has not yet been fully
assessed (18). Even when MRI guiding equipment is
available, lesions in the medial breast are difficult to access
and small enhancing lesions (around 5 mm) may be
difficult to localize due to the transient nature of contrast
enhancement and the obscuring that occurs when placing
the biopsy needle. MR imaging-guided biopsy or localiza-
tion is also a time-consuming procedure that lasts as long as
45 to 60 minutes (14, 17, 18).
A few studies have reported excellent performance of
MR-guided second-look US localization (11, 19). In our
study, MR-guided second-look examinations localized all
the lesions that were detected on breast MRI alone, with
the exception of one case of DCIS. Therefore, localization
with using MR-correlated mammography or MR-guided
second-look US can be a cheaper, practical imaging
alternative.
In our experience, the lesions that were negative on prior
US or mammography, but that were localized on MR-
correlated mammography or second-look sonography,
included not only suspicious malignant lesions, but also
benign-looking lesions (five category 3 lesions and one
category 2 lesion) that were small in size; all of these were
found to be malignant. However, two category 3 nodules
that were detected on prior US, but that did not correlate
with the MR findings, were revealed as benign lesions after
biopsy. When BI-RADS category 2 or 3 lesions are
detected on conventional images, but they do not correlate
with the MR findings of the patients with suspicious occult
breast cancer, then we should not neglect these lesions.
However, biopsy for all benign-looking lesions is not
desirable or even necessarily meaningful (6). Based on our
experience, we suggest that when there is a benign or
benign-looking lesion on the conventional images of the
patients with metastatic axillary lymph node(s) and an
unknown primary malignancy, then the conventional
images should first be correlated with MR findings before
performing a biopsy of the lesions.
In conclusion, the high sensitivity of contrast-enhanced
breast MRI played an essential role in evaluating occult
breast cancer in patients who presented with a metastatic
axillary lymph node with an unknown primary
malignancy, and contrast-enhanced breast MRI also played
an essential role for determining the therapeutic plan. In
90% of our cases, histologic work-up for the lesions
detected on the breast MRI was practically feasible with
successful localization being achieved under MR-guided
second-look US or MR-correlated mammography. 
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